A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Part of paid clinical trials in Long Beach, California.

Sponsor
Cedars-Sinai Medical Center
Study ID
NCT03193541
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Study Details

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

Key Dates

Start date
Dec 30, 2016
Status verified
Feb 2026
Primary completion
Feb 28, 2029
Completion
Feb 28, 2029

Study Design

Enrollment
900 participants (estimated)

Primary Outcome Measure

Sensitivity and specificity of multiplex ELISA assay will be confirmed by cystoscopy. [ Time Frame: 1 year ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
VA Long Beach Healthcare SystemLong BeachCalifornia90822
Cedars-Sinai Medical CenterLos AngelesCalifornia90048
Amy Oppenheim
[email protected]
310-423-3713
Hideki Furuya, PhD (PRINCIPAL_INVESTIGATOR)
UCLA Medical CenterLos AngelesCalifornia90095
Ankush Sachdeva
[email protected]
Hoag Memorial Hospital PresbyterianNewport BeachCalifornia92663
Clemente Reyes
[email protected]
949-791-3049
University of Rochester Medical CenterRochesterNew York14620
Natalie Carroll
[email protected]
UT Southwestern Medical Center at DallasDallasTexas75390
Maricruz Ibarra
[email protected]

Find similar trials in Long Beach, CA

By condition
Bladder cancer
By specialty
OncologyUrology
By research site
VA Long Beach Healthcare System· Long Beach, CACedars-Sinai Medical Center· Los Angeles, CAUCLA Medical Center· Los Angeles, CAHoag Memorial Hospital Presbyterian· Newport Beach, CAUniversity of Rochester Medical Center· Rochester, NYUT Southwestern Medical Center at Dallas· Dallas, TX

Related Studies